Adaptive Stent Graft Systems for Niche Environments

Publication ID: 24-11857407_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptive Stent Graft Systems for Niche Environments,” Published Technical Disclosure No. 24-11857407_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857407_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,407.

Summary of the Inventive Concept

This inventive concept discloses stent graft systems tailored for specific, challenging operational environments, including high-altitude, disaster relief, compromised immune systems, and extreme weather conditions.

Background and Problem Solved

The original patent describes implantable intraluminal medical devices, but these devices may not be suitable for unique operational environments. This inventive concept addresses the limitations of the original patent by providing specialized variations of stent graft systems for niche markets.

Detailed Description of the Inventive Concept

The new stent graft systems comprise a primary device with a helically arranged membranous strip and a helically arranged support member. The support member is adapted to withstand extreme pressure fluctuations at high-altitude environments, and the membranous strip can be treated with a low-temperature-resistant coating or an antimicrobial coating. The systems can be deployed rapidly in emergency situations or designed for use in extreme weather conditions.

Novelty and Inventive Step

The new claims introduce novel features, such as the adaptation of the support member for high-altitude environments, the use of low-temperature-resistant coatings, and the incorporation of antimicrobial coatings. These features provide a non-obvious solution for stent graft systems in niche environments.

Alternative Embodiments and Variations

Alternative embodiments may include stent graft systems with adjustable support members, modular designs for easy customization, or integrated sensors for real-time monitoring. Variations may also include different materials or surface treatments for the membranous strip and support member.

Potential Commercial Applications and Market

The adaptive stent graft systems have significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and peripheral vascular disease treatment. Target markets may include hospitals, clinics, and medical research institutions operating in challenging environments.

CPC Classifications

SectionClassGroup
A A61 A61F2/07
A A61 A61F2/04
A A61 A61F2/852
A A61 A61F2/88
A A61 A61F2/89
A A61 A61F2002/041
A A61 A61F2002/075
A A61 A61F2240/001
A A61 A61F2250/0065
Y Y10 Y10T29/49826

Field of Art

Medical device engineering, specifically intraluminal implantable devices such as stent grafts, requiring expertise in materials science, biomedical engineering, and surgical device design with knowledge of fluid dynamics, material properties, and anatomical constraints

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, 5-10 years experience in vascular implant design, familiar with material modification techniques, pressure/temperature tolerances, and surgical deployment strategies

Obviousness Rationale

A PHOSITA would recognize that the source patent's helical stent graft design inherently suggests adaptability through material and structural modifications. The PTD's variations represent predictable engineering solutions addressing specific environmental challenges using known techniques of material coating, structural reinforcement, and design customization. The core helical architecture remains consistent, with modifications representing standard design optimization approaches.

Obvious Combinations & Variations

Source Patent Element
Helically arranged membranous strip with overlapping turns allowing fluid communication
PTD Variation
Adding low-temperature-resistant coating to prevent embrittlement in extreme environments
Obviousness Reasoning
Material surface treatment is a standard engineering approach for extending device performance, representing a predictable solution to environmental stress using known coating technologies
Source Patent Element
Implantable medical device system with configurable tubular members
PTD Variation
Adapting support member to withstand high-altitude pressure fluctuations
Obviousness Reasoning
Modifying material properties to address specific environmental conditions is a routine design optimization strategy within medical device engineering
Source Patent Element
Helical stent graft with fluid communication channels
PTD Variation
Incorporating antimicrobial coating to reduce infection risk in immunocompromised patients
Obviousness Reasoning
Adding protective surface treatments to medical implants is a well-established technique for improving clinical outcomes, representing an obvious design enhancement
Source Patent Element
Configurable elongate tubular member with support structure
PTD Variation
Developing modular designs for rapid emergency deployment
Obviousness Reasoning
Designing medical devices for rapid deployment is a known requirement in emergency medical contexts, representing a standard engineering problem with predictable solution approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857407, the claimed variations in the present publication would be considered obvious to a person having ordinary skill in the art. The disclosed stent graft system modifications represent predictable engineering solutions utilizing standard material modification, coating, and structural adaptation techniques, thereby rendering subsequent claims involving similar environmental adaptations anticipated and non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,407
TitleImplantable intraluminal device
Assignee(s)W. L. Gore & Associates, Inc.